Insider Trading & Ownership - Reich Siegfried

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Reich Siegfried
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-02-09
Sale
2022-02-11
6:10 pm
Turning Point Therapeutics Inc.TPTXReich Siegfried
EVP & Chief Scientific Officer
397$36.3$14,41165,848
(Direct)
View
2021-03-04
Sale
2021-03-05
8:56 pm
Turning Point Therapeutics Inc.TPTXReich Siegfried
EVP & Chief Scientific Officer
35,550$105.04$3,734,075118,295
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-02-09
Option Award
2022-02-11
6:10 pm
N/A
2032-02-08
Turning Point Therapeutics Inc.TPTXReich Siegfried
EVP & Chief Scientific Officer
62,400$065,848
(Direct)
View
2021-03-04
Exercise
2021-03-05
8:56 pm
N/A
2030-03-01
Turning Point Therapeutics Inc.TPTXReich Siegfried
EVP & Chief Scientific Officer
35,550$0118,295
(Direct)
View
2021-03-04
Exercise
2021-03-05
8:56 pm
N/A
N/A
Turning Point Therapeutics Inc.TPTXReich Siegfried
EVP & Chief Scientific Officer
35,550$51.28118,295
(Direct)
View
2021-02-08
Option Award
2021-02-10
5:55 pm
N/A
2031-02-07
Turning Point Therapeutics Inc.TPTXReich Siegfried
EVP & Chief Scientific Officer
21,148$021,148
(Direct)
View
2020-03-02
Option Award
2020-03-02
7:11 pm
N/A
2030-03-01
Turning Point Therapeutics Inc.TPTXReich Siegfried
EVP & Chief Scientific Officer
150,000$0150,000
(Direct)
View